Global Pneumococcal Polysaccharide Vaccine Market Insights, Forecast to 2025

Publisher Name :
Date: 14-Jun-2019
No. of pages: 112
Inquire Before Buying

Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age.

The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23. 

The global Pneumococcal Polysaccharide Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pneumococcal Polysaccharide Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Pneumococcal Polysaccharide Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pneumococcal Polysaccharide Vaccine in these regions.

This research report categorizes the global Pneumococcal Polysaccharide Vaccine market by top players/brands, region, type and end user. This report also studies the global Pneumococcal Polysaccharide Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Merck & Co., Inc.

- Pfizer Inc.

- Glaxosmithkline Plc.

- Sanofi Pasteur

- China National Biotec Group

- Astellas Pharma Inc

- Serum Institute of India Pvt. Ltd

Market size by Product

- Single Dose Vial

- Pre-Filled Syringe

Market size by End User

- Children (2-10 Age)

- Adult (10-64 Age)

- Geriatric (More Than 65 Age)

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Pneumococcal Polysaccharide Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Pneumococcal Polysaccharide Vaccine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Pneumococcal Polysaccharide Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Pneumococcal Polysaccharide Vaccine submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pneumococcal Polysaccharide Vaccine are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pneumococcal Polysaccharide Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Pneumococcal Polysaccharide Vaccine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Pneumococcal Polysaccharide Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Product
1.4.2 Single Dose Vial
1.4.3 Pre-Filled Syringe
1.5 Market by End User
1.5.1 Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by End User
1.5.2 Children (2-10 Age)
1.5.3 Adult (10-64 Age)
1.5.4 Geriatric (More Than 65 Age)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pneumococcal Polysaccharide Vaccine Market Size
2.1.1 Global Pneumococcal Polysaccharide Vaccine Revenue 2014-2025
2.1.2 Global Pneumococcal Polysaccharide Vaccine Sales 2014-2025
2.2 Pneumococcal Polysaccharide Vaccine Growth Rate by Regions
2.2.1 Global Pneumococcal Polysaccharide Vaccine Sales by Regions
2.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
3.1.1 Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
3.1.2 Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers
3.1.3 Global Pneumococcal Polysaccharide Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers
3.2.1 Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Pneumococcal Polysaccharide Vaccine Price by Manufacturers
3.4 Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pneumococcal Polysaccharide Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Pneumococcal Polysaccharide Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Pneumococcal Polysaccharide Vaccine Sales by Product
4.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Product
4.3 Pneumococcal Polysaccharide Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Pneumococcal Polysaccharide Vaccine Breakdown Data by End User
6 North America
6.1 North America Pneumococcal Polysaccharide Vaccine by Countries
6.1.1 North America Pneumococcal Polysaccharide Vaccine Sales by Countries
6.1.2 North America Pneumococcal Polysaccharide Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pneumococcal Polysaccharide Vaccine by Product
6.3 North America Pneumococcal Polysaccharide Vaccine by End User
7 Europe
7.1 Europe Pneumococcal Polysaccharide Vaccine by Countries
7.1.1 Europe Pneumococcal Polysaccharide Vaccine Sales by Countries
7.1.2 Europe Pneumococcal Polysaccharide Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pneumococcal Polysaccharide Vaccine by Product
7.3 Europe Pneumococcal Polysaccharide Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Pneumococcal Polysaccharide Vaccine by Countries
8.1.1 Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Countries
8.1.2 Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pneumococcal Polysaccharide Vaccine by Product
8.3 Asia Pacific Pneumococcal Polysaccharide Vaccine by End User
9 Central & South America
9.1 Central & South America Pneumococcal Polysaccharide Vaccine by Countries
9.1.1 Central & South America Pneumococcal Polysaccharide Vaccine Sales by Countries
9.1.2 Central & South America Pneumococcal Polysaccharide Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pneumococcal Polysaccharide Vaccine by Product
9.3 Central & South America Pneumococcal Polysaccharide Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine by Countries
10.1.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Countries
10.1.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine by Product
10.3 Middle East and Africa Pneumococcal Polysaccharide Vaccine by End User
11 Company Profiles
11.1 Merck & Co., Inc.
11.1.1 Merck & Co., Inc. Company Details
11.1.2 Company Business Overview
11.1.3 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Products Offered
11.1.5 Merck & Co., Inc. Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer Inc. Pneumococcal Polysaccharide Vaccine Products Offered
11.2.5 Pfizer Inc. Recent Development
11.3 Glaxosmithkline Plc.
11.3.1 Glaxosmithkline Plc. Company Details
11.3.2 Company Business Overview
11.3.3 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Products Offered
11.3.5 Glaxosmithkline Plc. Recent Development
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Products Offered
11.4.5 Sanofi Pasteur Recent Development
11.5 China National Biotec Group
11.5.1 China National Biotec Group Company Details
11.5.2 Company Business Overview
11.5.3 China National Biotec Group Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 China National Biotec Group Pneumococcal Polysaccharide Vaccine Products Offered
11.5.5 China National Biotec Group Recent Development
11.6 Astellas Pharma Inc
11.6.1 Astellas Pharma Inc Company Details
11.6.2 Company Business Overview
11.6.3 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Products Offered
11.6.5 Astellas Pharma Inc Recent Development
11.7 Serum Institute of India Pvt. Ltd
11.7.1 Serum Institute of India Pvt. Ltd Company Details
11.7.2 Company Business Overview
11.7.3 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Products Offered
11.7.5 Serum Institute of India Pvt. Ltd Recent Development
12 Future Forecast
12.1 Pneumococcal Polysaccharide Vaccine Market Forecast by Regions
12.1.1 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Regions 2019-2025
12.2 Pneumococcal Polysaccharide Vaccine Market Forecast by Product
12.2.1 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Product 2019-2025
12.3 Pneumococcal Polysaccharide Vaccine Market Forecast by End User
12.4 North America Pneumococcal Polysaccharide Vaccine Forecast
12.5 Europe Pneumococcal Polysaccharide Vaccine Forecast
12.6 Asia Pacific Pneumococcal Polysaccharide Vaccine Forecast
12.7 Central & South America Pneumococcal Polysaccharide Vaccine Forecast
12.8 Middle East and Africa Pneumococcal Polysaccharide Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pneumococcal Polysaccharide Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Pneumococcal Polysaccharide Vaccine Product Picture
Table Pneumococcal Polysaccharide Vaccine Market Segments
Table Key Manufacturers Pneumococcal Polysaccharide Vaccine Covered
Table Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Product 2014-2025
Figure Single Dose Vial Product Picture
Table Major Manufacturers of Single Dose Vial
Figure Pre-Filled Syringe Product Picture
Table Major Manufacturers of Pre-Filled Syringe
Table Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Children (2-10 Age)
Figure Adult (10-64 Age)
Figure Geriatric (More Than 65 Age)
Figure Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure Global Pneumococcal Polysaccharide Vaccine Market Size 2014-2025 (Million US$)
Figure Global Pneumococcal Polysaccharide Vaccine Sales 2014-2025 (K Units)
Table Global Pneumococcal Polysaccharide Vaccine Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Pneumococcal Polysaccharide Vaccine Sales by Regions 2014-2019 (K Units)
Table Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions 2014-2019
Figure Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions
Table Global Pneumococcal Polysaccharide Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions
Table Global Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2014-2019) (K Units)
Table Global Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Pneumococcal Polysaccharide Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers Pneumococcal Polysaccharide Vaccine Price (2014-2019) (USD/Unit)
Table Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Pneumococcal Polysaccharide Vaccine Product Type
Table Date of International Manufacturers Enter into Pneumococcal Polysaccharide Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Pneumococcal Polysaccharide Vaccine Sales by Product (2014-2019) (K Units)
Table Global Pneumococcal Polysaccharide Vaccine Sales Share by Product (2014-2019)
Figure Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Product (2014-2019)
Figure Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Product in 2018
Table Global Pneumococcal Polysaccharide Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global Pneumococcal Polysaccharide Vaccine Revenue Share by Product (2014-2019)
Figure Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Product (2014-2019)
Figure Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Product in 2018
Table Pneumococcal Polysaccharide Vaccine Price by Product 2014-2019 (USD/Unit)
Table Global Pneumococcal Polysaccharide Vaccine Sales by End User (2014-2019) (K Units)
Table Global Pneumococcal Polysaccharide Vaccine Sales Share by End User (2014-2019)
Figure Global Sales Pneumococcal Polysaccharide Vaccine Market Share by End User (2014-2019)
Figure Global Sales Pneumococcal Polysaccharide Vaccine Market Share by End User in 2018
Figure North America Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure North America Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Pneumococcal Polysaccharide Vaccine Sales by Countries (2014-2019) (K Units)
Table North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries
Table North America Pneumococcal Polysaccharide Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries
Figure United States Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure United States Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Canada Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Pneumococcal Polysaccharide Vaccine Sales by Product (2014-2019) (K Units)
Table North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America Pneumococcal Polysaccharide Vaccine Market Share by Product
Table North America Pneumococcal Polysaccharide Vaccine Sales by End User (2014-2019) (K Units)
Table North America Pneumococcal Polysaccharide Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America Pneumococcal Polysaccharide Vaccine Market Share by End User
Figure Europe Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Europe Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Pneumococcal Polysaccharide Vaccine Sales by Countries (2014-2019) (K Units)
Table Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries
Table Europe Pneumococcal Polysaccharide Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries
Figure Germany Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Germany Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure France Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure UK Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Italy Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Russia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Pneumococcal Polysaccharide Vaccine Sales by Product (2014-2019) (K Units)
Table Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Pneumococcal Polysaccharide Vaccine Market Share by Product
Table Europe Pneumococcal Polysaccharide Vaccine Sales by End User (2014-2019) (K Units)
Table Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Pneumococcal Polysaccharide Vaccine Market Share by End User
Figure Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries
Table Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries
Figure China Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure China Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Japan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Korea Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure India Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Australia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Product (2014-2019) (K Units)
Table Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Share by Product
Table Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by End User (2014-2019) (K Units)
Table Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Share by End User
Figure Central & South America Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Pneumococcal Polysaccharide Vaccine Sales by Countries (2014-2019) (K Units)
Table Central & South America Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries
Table Central & South America Pneumococcal Polysaccharide Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries
Figure Brazil Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Pneumococcal Polysaccharide Vaccine Sales by Product (2014-2019) (K Units)
Table Central & South America Pneumococcal Polysaccharide Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Pneumococcal Polysaccharide Vaccine Market Share by Product
Table Central & South America Pneumococcal Polysaccharide Vaccine Sales by End User (2014-2019) (K Units)
Table Central & South America Pneumococcal Polysaccharide Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Pneumococcal Polysaccharide Vaccine Market Share by End User
Figure Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Countries
Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Countries
Figure GCC Countries Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Share by Product
Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Share by End User
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co., Inc. Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Inc. Recent Development
Table Glaxosmithkline Plc. Company Details
Table Glaxosmithkline Plc. Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Glaxosmithkline Plc. Recent Development
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Pasteur Recent Development
Table China National Biotec Group Company Details
Table China National Biotec Group Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table China National Biotec Group Recent Development
Table Astellas Pharma Inc Company Details
Table Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Pharma Inc Recent Development
Table Serum Institute of India Pvt. Ltd Company Details
Table Serum Institute of India Pvt. Ltd Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Serum Institute of India Pvt. Ltd Recent Development
Table Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Table Global Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Product 2019-2025 (K Units)
Table Global Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global Pneumococcal Polysaccharide Vaccine Sales Forecast by End User 2019-2025 (K Units)
Table Global Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America Pneumococcal Polysaccharide Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Pneumococcal Polysaccharide Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Pneumococcal Polysaccharide Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Pneumococcal Polysaccharide Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Pneumococcal Polysaccharide Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Pneumococcal Polysaccharide Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Pneumococcal Polysaccharide Vaccine Value Chain
Table Pneumococcal Polysaccharide Vaccine Customers List
Table Pneumococcal Polysaccharide Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs